Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18052605.
- Also identified by PMC identifier 2100139.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The author discusses a new study that found a common mutation in the connection domain of reverse transcriptase, a mutation that confers resistance to two antiretroviral drug classes.
Medical subject headings
- Drug Resistance, Multiple, Viral
- Genetic Testing
- HIV Infections
- HIV Reverse Transcriptase
- HIV-1
- Mutation
- Patient Selection
- Reverse Transcriptase Inhibitors